Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Fuji
AstraZeneca
Johnson and Johnson
US Department of Justice
Express Scripts
McKinsey
US Army
Baxter

Generated: November 18, 2018

DrugPatentWatch Database Preview

Idt Australia Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for IDT AUSTRALIA LTD, and what generic and branded alternatives to IDT AUSTRALIA LTD drugs are available?

IDT AUSTRALIA LTD has one approved drug.



Summary for Idt Australia Ltd
US Patents:0
Tradenames:1
Ingredients:1
NDAs:1
Drug Master File Entries: 5

Drugs and US Patents for Idt Australia Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Idt Australia Ltd TEMOZOLOMIDE temozolomide CAPSULE;ORAL 206413-002 Apr 12, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Idt Australia Ltd TEMOZOLOMIDE temozolomide CAPSULE;ORAL 206413-006 Apr 12, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Idt Australia Ltd TEMOZOLOMIDE temozolomide CAPSULE;ORAL 206413-003 Apr 12, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Idt Australia Ltd TEMOZOLOMIDE temozolomide CAPSULE;ORAL 206413-004 Apr 12, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Idt Australia Ltd TEMOZOLOMIDE temozolomide CAPSULE;ORAL 206413-005 Apr 12, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Idt Australia Ltd TEMOZOLOMIDE temozolomide CAPSULE;ORAL 206413-001 Apr 12, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Cantor Fitzgerald
QuintilesIMS
Covington
Harvard Business School
Accenture
Daiichi Sankyo
Chinese Patent Office
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.